Core Viewpoint - The report evaluates the risk management and operational status of China Minmetals Corporation's financial subsidiary, highlighting its compliance with regulations and effective risk control measures [1][10]. Group 1: Basic Information of the Financial Company - The financial company is a non-bank financial institution established in 1992, with a registered capital of RMB 500 million [1]. - It operates under the supervision of financial regulatory authorities and provides financial services to its parent group [2]. Group 2: Risk Management Framework - The financial company has established a robust governance structure, including a board of directors and a risk management committee to oversee risk management activities [2][3]. - It has implemented an internal control management system to identify and assess risks, ensuring clear responsibilities and reporting relationships among departments [3][4]. Group 3: Risk Control Activities - The company has developed detailed operational procedures for various financial activities, including settlement and fund management, to mitigate business risks [4][5]. - It employs a three-check system for credit operations, ensuring thorough investigation and approval processes to manage credit risks effectively [6]. Group 4: Operational and Financial Performance - As of June 30, 2025, the financial company reported total assets of RMB 50.301 billion, total liabilities of RMB 44.110 billion, and total equity of RMB 6.190 billion, with an asset-liability ratio of 87.69% [8]. - The company generated operating income of RMB 203 million and a net profit of RMB 99 million in the first half of 2025 [8]. Group 5: Regulatory Compliance and Risk Assessment - The financial company adheres to the regulations set forth in the Enterprise Group Financial Company Management Measures, with no significant risks identified as of June 30, 2025 [9][10]. - The company maintains a sound internal control system, ensuring compliance with financial regulations and effective risk management practices [10].

Core Viewpoint - The report evaluates the financial risk management of Wenkang Capital Co., Ltd. and its subsidiary, Wenkang Group Financial Co., Ltd., highlighting the company's compliance with regulatory requirements and effective risk control measures. Group 1: Company Overview - Wenkang Group Financial Co., Ltd. is a non-banking financial institution established in 1992, with a registered capital of RMB 3.5 billion [1] - The company is jointly funded by China Minmetals Corporation and Wenkang Capital Holdings Co., Ltd., and is regulated by the National Financial Supervision Administration [1] Group 2: Risk Management Structure - The company has established a governance structure including a shareholders' meeting, board of directors, and supervisory board, with clear responsibilities for risk management [1][2] - A Risk Management Committee, composed of non-executive directors, oversees comprehensive risk management and provides recommendations to the board [2] Group 3: Risk Identification and Assessment - The company has developed an Internal Control Management Method and established a clear division of responsibilities among departments to identify and assess risks [2] - The Risk Management Committee supervises risk control measures and evaluates the company's risk status [2] Group 4: Risk Control Activities - The company has implemented various management measures for settlement and fund management, including detailed operational procedures for each business activity [3] - The treasury system supports multi-level authorization for client operations, mitigating operational risks [3] Group 5: Credit Risk Management - The company follows strict credit management protocols, including pre-loan investigations and a three-check system to ensure risk control in lending activities [4] - Credit limits are determined based on financing needs and the company's financial status, ensuring planned and balanced business operations [4] Group 6: Operational and Financial Performance - As of June 30, 2025, the company reported total assets of RMB 50.301 billion, total liabilities of RMB 44.11 billion, and total equity of RMB 6.19 billion, with an asset-liability ratio of 87.69% [6] - The company achieved an operating income of RMB 203 million and a net profit of RMB 83 million in the first half of 2025, indicating stable operations [6] Group 7: Regulatory Compliance - The company adheres to the regulations set forth by the National Financial Supervision Administration and has not identified any significant deficiencies in its risk control systems [8] - All regulatory indicators are within reasonable limits, and there are no major risks identified as of June 30, 2025 [6][8]

Core Points - The company has completed the issuance of its fifth phase of corporate bonds aimed at professional investors, with a total issuance scale of 620 million RMB [2][3] - The bonds have a maturity of 5 years and a coupon rate of 2.56% [3] Summary by Sections Issuance Approval - The China Securities Regulatory Commission approved the registration for the public issuance of corporate bonds by the company's wholly-owned subsidiary, Wukuang Capital Holdings, with a total face value not exceeding 18 billion RMB [1] Issuance Details - The bonds, referred to as "25 Wuzi 06" with the bond code "243628," were issued at a price of 100 RMB per bond, over a period of 2 trading days from August 20 to August 21, 2025 [2] Financial Terms - The actual issuance scale of the bonds is 620 million RMB, with a maturity of 5 years and a fixed interest rate of 2.56% [3]

（公告编号：临2025-030） 近日，公司获五矿资本控股通知，其已完成2025年面向专业投资 者公开发行公司债券（第五期）的发行工作。根据《五矿资本控股有 限公司2025年面向专业投资者公开发行公司债券（第五期）发行结果 公告》 证券代码：600390 证券简称：五矿资本 公告编号：临 2025-051 五矿资本股份有限公司 关于全资子公司五矿资本控股有限公司 发行结果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中国证券监督管理委员会于2025年4月出具《关于同意五矿资本 控股有限公司向专业投资者公开发行公司债券注册的批复》（证监许 可[2025]843号），核准五矿资本股份有限公司（以下简称"公司"） 全资子公司五矿资本控股有限公司（公司债发行主体，以下简称"五 矿资本控股"）向专业投资者公开发行面值总额不超过180亿元的公 司债券，详细内容见公司于2025年4月30日在《上海证券报》、《中 国证券报》、《证券时报》及上海证券交易所网站（www.sse.com.cn） 披露的《五矿资本股份有限公司关于全资子公司 ...

Group 1 - Warner Pharmaceutical has experienced a decline for five consecutive trading days, with a cumulative drop of -10.00% [1] - Founded in 2001, Hunan Warner Pharmaceutical Co., Ltd. was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board in 2021 (stock code: 688799) and operates as an innovative drug manufacturing company covering traditional Chinese medicine, chemical drugs, and biopharmaceuticals [1] - Anxin Fund's Anxin Medical Health Stock A is among the top ten shareholders of Warner Pharmaceutical and has reduced its holdings in the second quarter of this year, achieving a year-to-date return of 69.42%, ranking 18th among 915 similar funds [1] Group 2 - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who holds a master's degree in economics and has previously worked as a researcher at various financial institutions [2][3] - Chi Chenshen has been managing the Anxin Medical Health Stock A fund since January 12, 2021, with a current fund size of 4.42 billion and a return of 65.80% during his tenure [3] - Anxin Fund Management Co., Ltd. was established in December 2011, with major shareholders including WISCO Capital Holdings Co., Ltd. (39.84%) and Guotou Securities Co., Ltd. (33.95%) [3]

Group 1 - The company has received approval from the China Securities Regulatory Commission to issue corporate bonds totaling up to 18 billion yuan through its wholly-owned subsidiary, Wukuang Capital Holdings [1] - Wukuang Capital Holdings has successfully completed the issuance of its fourth phase of corporate bonds, with a total issuance scale of 1.5 billion yuan [2] - The bonds, referred to as "25 Wuzi 05" with bond code "243504," have a maturity of 3 years and a coupon rate of 2.30% [2]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 特此公告。 五矿资本股份有限公司 董事会 2025年5月24日 中国证券监督管理委员会于2025年4月出具《关于同意五矿资本控股有限公司向专业投资者公开发行公 司债券注册的批复》（证监许可[2025]843号），核准公司全资子公司五矿资本控股有限公司（公司债 发行主体，以下简称"五矿资本控股"）向专业投资者公开发行面值总额不超过180亿元的公司债券，详 细内容见公司于2025年4月30日在《上海证券报》、《中国证券报》、《证券时报》及上海证券交易所 网站（www.sse.com.cn）披露的《五矿资本股份有限公司关于全资子公司公司债发行申请获得中国证券 监督管理委员会注册批复的公告》（公告编号：临2025-030）。 近日，五矿资本股份有限公司获五矿资本控股通知，其已完成2025年面向专业投资者公开发行公司债券 （第一期）的发行工作。根据《五矿资本控股有限公司2025年面向专业投资者公开发行公司债券（第一 期）发行结果公告》（2025年5月22日刊登于上海证券交易所网站www.s ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 三、本批复自同意注册之日起24个月内有效，五矿资本控股在注册有效期内可以分期发行公司债券。 四、自同意注册之日起至本次公司债券发行结束前，五矿资本控股如发生重大事项，应及时报告并按有 关规定处理。 五矿资本控股经营层将按照有关法律法规、中国证监会注册批复文件的要求，办理本次发行公司债券的 相关事宜，公司将及时履行信息披露义务。 特此公告。 五矿资本股份有限公司董事会 二○二五年四月三十日 2024年4月24日，五矿资本股份有限公司（以下简称"公司"）第九届董事会第十次会议审议通过了《关 于五矿资本控股有限公司注册发行公司债券的议案》，并经公司2023年年度股东大会审议批准，股东大 会授权公司及全资子公司五矿资本控股有限公司(以下简称"五矿资本控股")经理层全权负责办理与本次 注册、发行公司债券有关的一切事宜，详细内容见公司于2024年4月25日在《上海证券报》、《中国证 券报》、《证券时报》及上海证券交易所网站（www.sse.com.cn）披露的《五矿资本股份有限公司关于 五矿 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600390 证券简称：五矿资本 公告编号：临2025-030 五矿资本股份有限公司 关于全资子公司公司债发行申请获得 中国证券监督管理委员会注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 2024年4月24日，五矿资本股份有限公司（以下简称"公司"）第九届董事会第十次会议审议通过了《关 于五矿资本控股有限公司注册发行公司债券的议案》，并经公司2023年年度股东大会审议批准，股东大 会授权公司及全资子公司五矿资本控股有限公司(以下简称"五矿资本控股")经理层全权负责办理与本次 注册、发行公司债券有关的一切事宜，详细内容见公司于2024年4月25日在《上海证券报》、《中国证 券报》、《证券时报》及上海证券交易所网站（www.sse.com.cn）披露的《五矿资本股份有限公司关于 五矿资本控股有限公司注册发行公司债券的公告》（公告编号：临2024-016）。 五矿资本控股于近期收到中国证券监督管理委员会（以下简称"中国证监会"）印发的《关于同意五矿资 本控 ...

五矿资本（600390）公告，公司全资子公司五矿资本控股有限公司于近期收到中国证监会印发的《关于 同意五矿资本控股有限公司向专业投资者公开发行公司债券注册的批复》，同意其公开发行面值总额不 超过180亿元公司债券的注册申请。 ...